ArticleBMJ open respiratory research2021

Effects of infliximab on lung and circulating natural killer cells, CD56+ T cells and B cells in sarcoidosis.

Susanna Kullberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.